While great advances have been made for the robust, reliable and reproducible preparation of PET drugs through synthesis automation, release testing or quality control has seen limited innovation. Release testing is a time consuming and labor intensive process that uses multiple instruments to assess the product quality. This is a bottleneck in smaller production facilities that are producing multiple PET drugs on a daily basis, limiting the variety PET drugs that may be used by the clinic. Therefore, I enthusiastically support the Tracer-QC technology that will simplify the quality testing process while enhancing the both patient and worker safety. This is a paradigm shift that will streamline the quality assessment through parallel testing, reduced human interaction and elimination of other devices that each must be certified and maintained.